Effect of a contraceptive steroid combination of the "serum activation" of lipoprotein lipase in rats.
D000273:Adipose Tissue / Q000201:enzymology; D000818:Animals; D002914:Chylomicrons / Q000378:metabolism; D003276:Contraceptives, Oral / Q000494:pharmacology*; D003277:Contraceptives, Oral, Combined / Q000494:pharmacology*; D003280:Contraceptives, Oral, Synthetic / Q000494:pharmacology*; D004789:Enzyme Activation / Q000187:drug effects; D005260:Female; D008071:Lipoprotein Lipase / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008234:Lynestrenol / Q000031:analogs & derivatives / Q000494:pharmacology; D008656:Mestranol / Q000494:pharmacology; D051381:Rats; D014280:Triglycerides / Q000378:metabolism
D002914:Chylomicrons; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003280:Contraceptives, Oral, Synthetic; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D008656:Mestranol; D008071:Lipoprotein Lipase; D008234:Lynestrenol